On August 19, 2021, Reshma Kewalramani – CEO and President of Vertex Pharmaceuticals Incorporated (VRTX) – purchased 10,000 shares of VRTX at $195.65. His out of pocket cost was $1,956,492.
Insider Buying in Vertex Pharmaceuticals Incorporated (VRTX)
